75% of adults age 50+ want to remain in their current homes as they age.
AARP Home and Community Preferences Survey · as of 2024-12-10Clarity Circle company overview
Connection now. Better context for care in the future.
Clarity Circle is building a consumer Companion as the commercial entry point to a longer-term, patent-pending technology platform for respectful longitudinal insight.
This overview provides general company information. It is not an offer to sell or a solicitation to buy securities, and no investment transaction occurs on this website.
The company-building sequence
- NowLaunch Claire CompanionLearn from families and establish a consumer revenue engine.
- NextBuild longitudinal contextDevelop the consent, provenance, and data foundation.
- FuturePursue a regulated platformValidate neuromonitoring and clinician workflows separately.
The human and economic context
A large need, grounded in lived family experience.
Nearly 13 million Americans provide unpaid care for people with Alzheimer’s or other dementias.
Alzheimer’s Association 2026 Facts and Figures · as of 2026-04-21U.S. health and long-term care costs for people living with dementia are projected to reach $409 billion in 2026.
Alzheimer’s Association 2026 Facts and Figures · as of 2026-04-21The thesis
A near-term product with a deliberately staged platform roadmap.
Clarity Circle begins where customer value and product learning can start now: a consumer relationship with families. The regulated opportunity is a separate horizon with separate evidence, regulatory, and reimbursement requirements.
Current Companion
A customer and learning wedge
Claire is a non-diagnostic consumer Companion being prepared for family beta. Her purpose is conversation, family-contributed memories, reminders, and consent-led connection.
Product boundary
The current Companion does not diagnose, score, monitor, or treat cognitive impairment and is not an emergency service.
Patent pending
A consent and provenance architecture
The filed invention addresses elements of a proposed longitudinal neuromonitoring architecture, including how observations may be permissioned, attributed, and evaluated over time.
What patent pending means
An application has been filed. No patent has been granted, no claim scope is assured, and prosecution outcomes remain uncertain.
Future regulated development goal
A future clinical information layer
The long-term direction is to develop and validate technology that may help surface meaningful longitudinal change and support clinician evaluation workflows.
Regulatory boundary
Medical use, FDA authorization, clinical performance, and reimbursement are future milestones. Classification, evidence requirements, coverage, and timing are not yet assured.
Mission
Help more seniors remain safely at home
The company is organized around independence, earlier attention to meaningful change, and technology that strengthens the circle of family and professional care.
Impact boundary
Mission does not substitute for evidence. Adoption, outcomes, access, and caregiver benefit must be measured rather than assumed.
Milestone logic
Each horizon has a different proof burden.
Family beta
Validate usability, engagement, consent experience, and the problems families will pay to solve.
Companion launch
Establish customer acquisition, retention, and a recurring consumer business.
Evidence foundation
Advance data governance, regulatory consultation, and clinical validation planning.
Regulated development
Develop, test, and pursue the authorization and reimbursement routes supported by evidence.
Material dependencies
A compelling opportunity still has real execution risk.
Our approach is to make dependencies visible and turn them into staged decisions, without implying that future outcomes are assured.
Consumer adoption
Families may not adopt, retain, or pay for the Companion at the levels needed to support the business.
Clinical and regulatory evidence
Future medical claims require appropriate validation and authorization. Required studies, classification, cost, and timing may change.
Intellectual property
Patent prosecution is uncertain, competitors may pursue alternatives, and any eventual claim scope may be narrower than planned.
Privacy and data governance
Trust depends on consent, security, provenance, appropriate data use, and evolving legal requirements.
Capital and execution
The company will require sufficient financing, talent, operating discipline, and partner coordination to reach its milestones.
Continue the conversation
Request investor materials.
Tell us how to reach you and, if helpful, a little about your perspective. A company representative will follow up personally with the materials and next step appropriate to the company’s approved fundraising pathway.
What happens next
We review each request, reply by email, and provide only materials approved for that follow-up. This form does not qualify, verify, or accept investors.